Association between Hasford scoring system and hematologic response in chronic and accelerated phase of chronic myelocytic leukemia patient with imatinib for …
A Purnomo, SUY Bintoro, MP Sedana… - Molecular and …, 2019 - repository.unair.ac.id
Background: Hasford score is a scoring system which was made in interferon treatment era
to assess chronic myelocytic leukemia (CML) prognosis. Complete hematologic response …
to assess chronic myelocytic leukemia (CML) prognosis. Complete hematologic response …
[PDF][PDF] Clinico-Hematological Profile in patients with chronic myeloid leukemia
I Al-abady, MA Kashmoola, KNM Al-Khero - Annals Coll Med Mosul, 2021 - iasj.net
Background: Chronic myeloid leukemia (CML) is a clonal malignant neoplasms of
pluripotent hematopoietic stem cell described by the excessive proliferation of mature …
pluripotent hematopoietic stem cell described by the excessive proliferation of mature …
Stratification of Chronic Myeloid Leukemia Cancer Dataset into Risk Groups using Four Machine Learning Algorithms with Minimal Loss Functi
Chronic Myeloid Leukemia (CML) had been stratified into risk groups using scoring systems
but these systems have limitation of overfitting data. Machine Learning (ML) algorithms were …
but these systems have limitation of overfitting data. Machine Learning (ML) algorithms were …
Correlation between hasford score with early molecular response in patients with chronic myeloid leukemia in chronic phase treated with imatinib
IDMW Hersana, SUY Bintoro… - Biomedical & …, 2019 - repository.unair.ac.id
Telah diperiksa dan divalidasi dengan baik, dan sampai pemyataan ini dibuat sebagai
karya ilmiah original, fhgne $ r sehingga kami turut bertanggung jawab bahwa karya ilmiah …
karya ilmiah original, fhgne $ r sehingga kami turut bertanggung jawab bahwa karya ilmiah …
Korelasi skor sokal terhadap respons molekuler mayor pada penderita chronic myeloid leukemia yang mendapat terapi nilotinib
M Riswan, SE Pratama, M Fuad… - Jurnal Kedokteran Syiah …, 2023 - jurnal.usk.ac.id
Chronic Myeloid Leukemia (CML) adalah penyakit mieloproliferatif dengan peningkatan
proliferasi sel induk hematopoietik seri mieloid pada berbagai stadium diferensiasi. Saat ini …
proliferasi sel induk hematopoietik seri mieloid pada berbagai stadium diferensiasi. Saat ini …
Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate
ND Eyüpoğlu, OE Çınar, S Aksu, Y Büyükaşık… - Acta Medica, 2022 - actamedica.org
Objective: Chronic myeloid leukemia (CML) prognostication at the time of diagnosis is
critical to determine the intensity of initial treatment. Event-free survival (EFS) has become a …
critical to determine the intensity of initial treatment. Event-free survival (EFS) has become a …
[PDF][PDF] Validations of Prognostic Scoring Systems in Iraqi Patients with Chronic Myeloid Leukemia in Single Center
HS Al-Mafragy, HAR Al-Awade - blood - researchgate.net
Chronic myeloid leukemia and known as chronic myelogenous leukemia (CML) is one of the
indolent myeloproliferative neoplasms. It is characterized by the presence of the …
indolent myeloproliferative neoplasms. It is characterized by the presence of the …
[PDF][PDF] Why Imatinib is by Far the Best Drug to Treat Chronic Myeloid Leukemia
J Kamini - Biochem Mol Biol Lett, 2017 - hakon-art.com
The objective of chronic myeloid leukemia treatment is to remove the platelets that contain
the strange BCR-ABL gene that causes the high number of infected platelets. For the vast …
the strange BCR-ABL gene that causes the high number of infected platelets. For the vast …
[PDF][PDF] Research and Reviews: Journal of Medical and Health Sciences
T Saad, AS Tirkey - academia.edu
Research and Reviews: Journal of Medical and Health Sciences Page 1 e-ISSN: 2319-9865
p-ISSN: 2322-0104 RRJMHS | Volume 3 | Issue 1 | January - March, 2014 126 Research and …
p-ISSN: 2322-0104 RRJMHS | Volume 3 | Issue 1 | January - March, 2014 126 Research and …